Bibliography
- Eikelenboom P , van Exel E, Hoozemans JJM, Veerhuis R, Rozemuller AJM, van Gool WA. Neuroinflammation- an early event in both the history and pathogenesis of Alzheimer‘s disease. Neurodegenerative Disease7 , 38–41 (2010).
- Giunta S . Exploring the complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflamm-aging, from robustness to frailty. Inflamm. Res.57 , 558–563 (2008).
- Noble JM , ManlyJJ, SchupfN, TangMX, MayeuxR, LuchsingerJA. Association of C-reactive protein with cognitive impairment. Arch. Neurol.67 , 87–92 (2010).
- Gunstad J , BaussermanL, PaulRH et al. C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J. Clin. Neurosci. 13 , 540–546 (2006).
- Marsland AL , PetersenKL, SathanooriR et al. Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers. Psychosom. Med. 68 , 895–903 (2006).
- Marioni RE , StewartMC, MurrayGD et al. Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia. Psychosom. Med. 71 , 901–906 (2009).
- Anan F , MasakiT, ShimomuraT et al. High-sensitivity C-reactive protein is associated with hippocampus volume in nondementia patients with Type 2 diabetes mellitus. Metabolism 60 , 460–466 (2011).
- Jefferson AL , MassaroJM, WolfPA et al. Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology 68 , 1032–1038 (2007).
- Wersching H , DuningT, LohmannH et al. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology 74 , 1022–1029 (2010).
- Rafnsson SB , DearyIJ, SmithFB et al. Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study. J. Am. Geriatr. Soc. 55 , 700–707 (2007).
- Schram MT , EuserSM, de Craen AJ et al. Systemic markers of inflammation and cognitive decline in old age. J. Am. Geriatr. Soc.55 , 708–716 (2007).
- Yaffe K , KanayaA, LindquistK et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292 , 2237–2242 (2004).
- Engelhart MJ , GeerlingsMI, MeijerJ et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch. Neurol. 61 , 668–672 (2004).
- Diniz BS , TeixeiraAL, OjopiEB et al. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer‘s disease. J. Alzheimers Dis. 22 , 1305–1311 (2010).
- Gimeno D , MarmotMG, Singh-ManouxA. Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology33 , 1322–1334 (2008).
- Dik MG , JonkerC, HackCE, SmitJH, ComijsHC, EikelenboomP. Serum inflammatory proteins and cognitive decline in older persons. Neurology64 , 1371–1377 (2005).
- Alley DE , CrimminsEM, KarlamanglaA, HuP, SeemanTE. Inflammation and rate of cognitive change in high-functioning older adults. J. Gerontol. A Biol. Sci. Med. Sci.63 , 50–55 (2008).
- Holmes C , El-OklM, WilliamsAL, CunninghamC, WilcocksonD, PerryVH. Systemic infection, interleukin-1β, and cognitive decline in Alzheimer‘s disease. J. Neurol. Neurosurg. Psychiatry74 , 788–789 (2003).
- Sprague AH , KhalilRA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem. Pharmacol.78 , 539–552 (2009).